These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26710333)

  • 1. Plasma lipoprotein(a) predicts major cardiovascular events in patients with chronic kidney disease who undergo percutaneous coronary intervention.
    Konishi H; Miyauchi K; Tsuboi S; Ogita M; Naito R; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
    Int J Cardiol; 2016 Feb; 205():50-53. PubMed ID: 26710333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.
    Konishi H; Miyauchi K; Shitara J; Endo H; Wada H; Doi S; Naito R; Tsuboi S; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Am J Cardiol; 2016 Dec; 118(12):1781-1785. PubMed ID: 27712648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Plasma Lipoprotein(a) With Long-Term Adverse Events in Patients With Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
    Xu N; Tang XF; Yao Y; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Am J Cardiol; 2018 Dec; 122(12):2043-2048. PubMed ID: 30477725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lipoprotein(a) as residual risk on long-term outcomes in patients after percutaneous coronary intervention.
    Konishi H; Miyauchi K; Kasai T; Tsuboi S; Ogita M; Naito R; Sai E; Fukushima Y; Katoh Y; Okai I; Tamura H; Okazaki S; Daida H
    Am J Cardiol; 2015 Jan; 115(2):157-60. PubMed ID: 25476560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention.
    Suwa S; Ogita M; Miyauchi K; Sonoda T; Konishi H; Tsuboi S; Wada H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Daida H
    J Atheroscler Thromb; 2017 Nov; 24(11):1125-1131. PubMed ID: 28321012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.
    Watabe H; Sato A; Hoshi T; Takeyasu N; Abe D; Akiyama D; Kakefuda Y; Nishina H; Noguchi Y; Aonuma K
    Int J Cardiol; 2014 Jun; 174(1):57-63. PubMed ID: 24726211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
    Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
    BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long-Term Follow-up Study on Real-World Patients Receiving Percutaneous Coronary Intervention.
    Liu HH; Cao YX; Jin JL; Zhang HW; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Xu RX; Chen XH; Li JJ
    J Am Heart Assoc; 2020 Feb; 9(3):e014581. PubMed ID: 32013705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lipoprotein(a) with long-term mortality following coronary angiography or percutaneous coronary intervention.
    Feng Z; Li HL; Bei WJ; Guo XS; Wang K; Yi SX; Luo DM; Li XD; Chen SQ; Ran P; Chen PY; Islam SMS; Chen JY; Liu Y; Zhou YL
    Clin Cardiol; 2017 Sep; 40(9):674-678. PubMed ID: 28444976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention.
    Weiss MC; Berger JS; Gianos E; Fisher E; Schwartzbard A; Underberg J; Weintraub H
    J Clin Lipidol; 2017; 11(5):1177-1180. PubMed ID: 28801030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
    Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
    Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction.
    Mitsuda T; Uemura Y; Ishii H; Takemoto K; Uchikawa T; Koyasu M; Ishikawa S; Miura A; Imai R; Iwamiya S; Ozaki Y; Kato T; Shibata R; Watarai M; Murohara T
    Heart Vessels; 2016 Dec; 31(12):1923-1929. PubMed ID: 26936452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease.
    Lautamäki A; Kiviniemi T; Biancari F; Airaksinen J; Juvonen T; Gunn J
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):926-30. PubMed ID: 26142469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Lipoprotein (a) Levels on Long-Term Outcomes in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction.
    Shitara J; Kasai T; Konishi H; Endo H; Wada H; Doi S; Naito R; Tsuboi S; Ogita M; Dohi T; Okazaki S; Miyauchi K; Daida H
    Circ J; 2019 Apr; 83(5):1047-1053. PubMed ID: 30918220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome.
    Dohi T; Kasai T; Miyauchi K; Takasu K; Kajimoto K; Kubota N; Amano A; Daida H
    J Cardiol; 2012 Dec; 60(6):438-42. PubMed ID: 23063662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention.
    Gupta T; Paul N; Kolte D; Harikrishnan P; Khera S; Aronow WS; Mujib M; Palaniswamy C; Sule S; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
    J Am Heart Assoc; 2015 Jun; 4(6):e002069. PubMed ID: 26080814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.